North Star Asset Management’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $476K | Sell |
41,093
-6,494
| -14% | -$75.2K | 0.02% | 228 |
|
|
2025
Q1 | $415K | Sell |
47,587
-40
| -0.1% | -$349 | 0.02% | 232 |
|
|
2024
Q4 | $684K | Sell |
47,627
-10,359
| -18% | -$149K | 0.03% | 198 |
|
|
2024
Q3 | $1.31M | Buy |
57,986
+4,837
| +9% | +$109K | 0.06% | 161 |
|
|
2024
Q2 | $1.03M | Buy |
53,149
+9,514
| +22% | +$185K | 0.05% | 169 |
|
|
2024
Q1 | $1.64M | Buy |
43,635
+2,986
| +7% | +$112K | 0.08% | 144 |
|
|
2023
Q4 | $2.27M | Sell |
40,649
-1,136
| -3% | -$63.6K | 0.12% | 123 |
|
|
2023
Q3 | $1.72M | Buy |
41,785
+920
| +2% | +$38K | 0.1% | 136 |
|
|
2023
Q2 | $2.28M | Sell |
40,865
-210
| -0.5% | -$11.7K | 0.13% | 124 |
|
|
2023
Q1 | $2.29M | Buy |
41,075
+5,126
| +14% | +$286K | 0.13% | 121 |
|
|
2022
Q4 | $1.31M | Buy |
35,949
+1,641
| +5% | +$59.8K | 0.08% | 145 |
|
|
2022
Q3 | $977K | Sell |
34,308
-5,664
| -14% | -$161K | 0.07% | 153 |
|
|
2022
Q2 | $1.81M | Sell |
39,972
-331
| -0.8% | -$15K | 0.12% | 126 |
|
|
2022
Q1 | $3.07M | Buy |
40,303
+5,652
| +16% | +$430K | 0.17% | 111 |
|
|
2021
Q4 | $5.16M | Buy |
34,651
+1,902
| +6% | +$283K | 0.26% | 91 |
|
|
2021
Q3 | $4.77M | Buy |
32,749
+10,111
| +45% | +$1.47M | 0.26% | 94 |
|
|
2021
Q2 | $4.43M | Buy |
22,638
+3,104
| +16% | +$608K | 0.25% | 96 |
|
|
2021
Q1 | $3.54M | Buy |
+19,534
| New | +$3.54M | 0.21% | 103 |
|